OssiMend BA in Posterolateral Instrumented Lumbar Fusion

Recruiting now

Conditions studied: Spinal Disease, Degenerative Disc Disease

In brief

The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material

Key facts

Study ID
NCT04775537
Run by
Collagen Matrix
People needed
120
Starts
2021-01-21
Expected to finish
2027-01-30
Last updated by the study team
2025-10-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.